44,662 results on '"Thyroid diseases"'
Search Results
2. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
3. Active Surveillance Program in Thyroid Nodules
4. Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.
5. Natural History Study of Children and Adults With Medullary Thyroid Cancer
6. Quality of Life After Interventional Thyroid Treatment (DSR)
7. Studies on Tumors of the Thyroid
8. AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
9. Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
10. Cryoablation of Benign Thyroid Nodules: a Pilot Study
11. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
12. Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
13. Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated with Radioactive Iodine for Thyroid Cancer
14. Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody (LIGHT)
15. Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab (QT-LIFE)
16. Bevacizumab and Temsirolimus Alone or in Combination with Valproic Acid or Cetuximab in Treating Patients with Advanced or Metastatic Malignancy or Other Benign Disease
17. A Study of IBI311 in Subjects With Inactive or Active Thyroid Eye Disease
18. A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease (SatraGO-2)
19. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
20. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
21. Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib (JPMS-DTC)
22. Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
23. Thyroid Hormone for Thyroid Cancer (T4T)
24. A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
25. Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
26. A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease (spiriTED)
27. Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
28. Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
29. [177Lu]Lu-AKIR001 First-in-human Study (AKIR001)
30. A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease
31. A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease (SatraGO-1)
32. Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
33. Sacituzumab govitEcan in THYroid Cancers (SETHY)
34. A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
35. Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
36. A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease (UplighTED)
37. A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers
38. A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease. (UplighTED)
39. Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
40. Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
41. Radiofrequency Ablation of Papillary Thyroid Microcarcinoma
42. Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer
43. Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
44. A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease
45. Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer (AS-PTC)
46. Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
47. Iodine Status and Characteristics of Papillary Thyroid Cancer
48. Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY (PTC-ARRAY)
49. An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Active Thyroid Eye Disease (TED) (REVEAL-1)
50. An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Chronic Thyroid Eye Disease (TED) (REVEAL-2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.